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Recent studies investigating the regulation of delayed-type hypersensitivity (DTH)1 
to p-azobenzenearsonate (ABA)-coupled cells have provided conclusive evidence for 
two  distinct  populations  or  subsets  of interacting  suppressor  T  cells  (Ts)  in  the 
suppressor pathway (1, 2). 
In  the  ABA  system,  the  subcutaneous  injection  of ABA-conjugated  spleen  cells 
(ABA-SC) induces T  cell-mediated (TDrt) delayed hypersensitivity. In contrast, intra- 
venous administration of ABA-SC induces suppressor T  cells (termed Tsl) that bind 
to  antigen-coupled  plates  and  express  cross-reactive  idiotypic  (CRI)  determinants 
serologically similar to those present on antibodies specific for the same hapten (3, 4). 
Furthermore,  second-order  suppressor T  cells  (Ts2)  are  induced  by a  CRI-bearing 
suppressor T  cell factor (TsF) termed TsFI or by CRI-conjugated spleen cells (CRI- 
SC) and bind to idiotype-coupled polystyrene plates (5, 6). Recently, similar data on 
the  specificity of Tsl  and  Ts2 have also  been obtained  in  a  hapten-specific system 
using 4-hydroxy-3-nitrophenyl aeetyl (7). Additional studies have shown that idiotype- 
bearing Tsl act only in  an afferent mode, i.e., when  administered  at  the induction 
phase of the  immune response,  whereas  anti-idiotypic  suppressor T  cells  (Ts2)  are 
* Supported by grants AI-16396-01, AI-14732, AI-12907, and AI-12895 from the National Institutes of 
Health. 
Department of Biology, Rosensteil Basic Research Center, Brandeis University, Waltham,  Mass. 
02254. 
1 Abbreviations used in th,s paper: ABA, p-azobenzenearsonate; ABA-SC, ABA-coupled syngeneic spleen 
cells; CRI, cross-reactive  idiotypic antibody from A/J mice; CRI-SC, CRI-coupled syngeneic spleen cells; 
DNFB, 2,4-dinitro-l-fluorobenzene; DTH, delayed type hypersensitivity; HBSS, Hanks' balanced salt 
solution; LN, lymph node; MHC, major histocompatibility complex; Ta~, auxiliary suppressor T cells; 
TDH, T cells that mediate DTH; Ts, T suppressor cells; Tsa, first-order  Ts (induced by ABA-SC [idiotype 
positive]); Ts2, second-order Ts (induced by CRI-SC [anti-idiotypic]); Ts3, third-order T cell subset that 
serves as target of Ts2; TsF, suppressor T cell factor; TsFI, TsF produced by Tsl; TsF2, TsF produced by 
Ts2. 
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efferent suppressors,  active when transferred either at  the time of immunization or 
challenge (8). In studies of the A/J humoral response, Ts with anti-idiotypic receptors 
(9) and TsF with either idiotypic or anti-idiotypic receptors (10) have been identified. 
The experiments on DTH performed in the ABA system have revealed an interest- 
ing paradox. The efferent suppressors (Ts2) are anti-idiotypic, and are able to suppress, 
upon  adoptive  transfer,  an  ABA-specific  DTH  reaction  in  syngeneic mice  in  the 
efferent phase. Yet, the DTH T  effector cells, the ultimate targets of the suppression, 
do not bear serologically detectable idiotypic determinants; they are not lysed by anti- 
idiotypic antibody and  complement  (11).  Moreover, we  have recently determined 
that the failure of idiotype-coupled spleen cells, which stimulate anti-idiotypic Ts in 
A/J mice to induce T  cell-mediated unresponsiveness in animals lacking the appro- 
priate variable region of the Ig heavy chain (VH) genes, appears to be a result of the 
lack of idiotype-matched targets (6). Thus, CRI-bearing antibodies from A/J  (H-2  a, 
Igh-1 e) mice were conjugated to normal BALB/c (H-2  'l, Igh-1 ~) spleen cells in vitro. 
The  CRI-bearing  syngeneic  cells,  when  injected  intravenously  into  syngeneic 
BALB/c mice, failed to induce tolerance in these animals.  Nevertheless, spleen cells 
taken from these CRI-SC-treated BALB/c animals transferred significant degrees of 
suppression to Igh-l-congenic C.AL-20 (H-2  d, Igh-1 d) but not to H-2 congenic, Igh-1 
disparate B10.D2 (H-2  d, Igh-1 b) mice (C.AL-20 mice but not BALB/c or B10.D2 mice 
express the CRI in their humoral antibody). We concluded from these experiments 
that appropriate anti-idiotype and idiotype interactions are necessary for the expres- 
sion  of Ts2  function,  and  that  the  target  of these  anti-idiotypic  Ts2  must  be  an 
idiotype-bearing cell. We speculated that these putative idiotype-bearing cells might 
be the precursors of the DTH effector cells or might represent helper T  cells for the 
DTH response. Alternatively, we proposed that  a  population of idiotype-positive T 
cells--other than the TDH cells or T  helper cells-- in the immune cell population may 
be the next, and perhaps last, T  cell in the suppressor pathway. Such a cell has been 
shown previously to be required for in the suppression of the contact sensitivity to 2,4- 
dinitro-l-fluorobenzene (DNFB)  (12). 
This  communication  reports  experiments  that  identify  and  characterize  these 
idiotype-bearing  target  ceils.  Anti-idiotypic  Ts2  block  the  efferent  step  of DTH 
reactions by interacting with a population of idiotype-bearing Ts cells, which reside 
in  the  immune  lymph  node  population,  and  which  we  have  termed  third-order 
suppressor  cells,  or Ts3.  Furthermore,  incubation  of Ts~  with  the  appropriate  Ts3 
results in suppression which is nonspecific for idiotype. Thus, these idiotype-bearing 
Ts3  represent  another  set  of suppressor  cells  in  a  coordinated  series  of cellular 
interactions determined by complementary receptor-anti-receptor binding. 
Materials and Methods 
Mice.  Female BALB/c (H-2  d, Igh-la),  and BI0.D2 (H-2  a, Igh-lb)d mice were obtained from 
C.AL-20 (H-2 , Igh-1 ) mice were obtained from  The Jackson Laboratory, Bar Harbor, Maine.  d 
the breeding colonies maintained at Brandeis University, Waltham, Mass. from stock originally 
provided by Dr. Michael Potter at the National Institutes  of Health, Bethesda,  Md. 
Preparation of AnOgen and Antigen-coupled Cells. These methods have been described  in detail 
elsewhere (3). Briefly, a 40-mM solution ofABA diazonium salt was prepared from recrystaUized 
p-arsanilic  acid (Eastman Kodak Co., Rochester, N. Y.). The ABA solution was activated and 
conjugated to single-cell suspensions of erythrocyte-free  splenocytes at a final concentration of 
10 mM ABA. After washing in Hanks' balanced salt solution  (HBSS), the ABA-SC were used 
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Preparation of Idiotype-coupled Cells.  The  method  used  for  coupling anti-ABA antibodies to 
spleen cells is a  modification of the method of Wetzig et al.  (13)  and has been described in 
detail elsewhere  (14).  Briefly, a  single-cell suspension of normal spleen cells was prepared  in 
HBSS. Erythrocytes were lysed by treatment with isotonic Tris-buffered ammonium chloride 
(pH  7.6).  The spleen cells were then washed three times in HBSS and once in 0.8% NaC1; 4 
×  108-5  ×  10  a washed  spleen cells were  pelleted  into a  17-  ×  100-mm  Falcon plastic tube 
(Falcon Labware, Div. of Becton, Dickinson, & Co., Oxnard, Calif.) and were resuspended in 
1 ml of a  1 mg/ml solution in saline of CRI  + ligand, affinity-purified (15), anti-ABA antibodies 
from A/J mice. The ceils and the antibody solution were transferred to a small glass scintillation 
vial (15 X  60 mm) and 25 mg of crystalline 1-ethyl-3(3'-dimethylaminopropyl) carbodiimide 
(ECDI; Pierce Chemical Co., Rockford, Ill.) was dissolved in the coupling solution. The reaction 
was allowed to  proceed  for 90 min at  4°C with gentle stirring.  (The coupling efficiency, as 
determined by using radiolabeled anti-ABA, was -5-10%.) The CRI-coupled spleen cells (CRI- 
SC) were washed twice in HBSS, adjusted to a concentration of 1 X  10a/ml, and 0.5 ml of the 
suspension was injected intravenously into appropriate recipients. 
Induction and Elicitation of DTH to ABA.  To induce DTH to ABA, a  total of 3 ×  107 ABA- 
coupled syngeneic cells were injected s.c.  into separate sites on the dorsal flanks of the mice. 
Challenge was performed 5 d  later by injecting 30 #1 of 10 mM diazonium salt ofp-arsanilic 
acid into the left footpad.  24 h  after the footpad challenge, DTH reactivity was assessed by 
measuring the  swelling of the  footpad  using a  Fowler micrometer  (Schlesinger's for  Tools, 
Brooklyn, N. Y.). The magnitude of the DTH was expressed as the increment of the thickness 
of the challenged left footpad  as compared  with the untreated right  footpad.  Responses are 
given in units of 10  -2 mm +  SEM. 
Transfer of Immunity  with Immune Lymph  Node Cells.  Animals were killed 4  or 5 d  after s.c. 
immunization with  3  ×  l0  T ABA-coupled spleen cells and draining lymph nodes  (bilateral, 
inguinal, and axillary) were obtained and made into single-cell suspensions as described earlier 
(3).  Cells were washed twice with HBSS and resuspended in HBSS at a concentration of 1 × 
l0  s cells/ml; 0.5 ml of the cell suspension, containing 5 X  10  s cells, was injected i.v. into groups 
of syngeneic recipients. Within 2  h  after cell transfer, recipient mice were challenged in the 
footpad with 30/~1 of the diazonium salt as described (3). 
Induction of Suppressor T  Cells and  the  Blocking of Passive Transfer of Immunity  with  Suppressor 
Cells.  Normal mice were injected 5 ×  107 CRI-SC. 7 d afterwards, these mice were killed and 
served as donors of suppressor T  cells. Spleens from such animals were removed, and a single- 
cell suspension was  prepared  in chilled  HBSS.  The  cells were  washed  twice in  HBSS  and 
counted; 5 ×  107 viable cells were injected i.v. into normal recipients, which were then primed 
s.c. with 3 ×  10  v ABA-SC and challenged 5 d later. 
To measure the ability of these suppressor cells to block the passive transfer of immunity 
(efferent route), immune T  cells were first mixed with suppressor T  cells in vitro. They were 
then cotransferred to naive recipients. Footpad challenges with the diazonium salt were done 
within  1 h  after cell transfer and increases in footpad swelling were measured 24 h  later, as 
described. Controls were mice in which immune T  cells were transferred without suppressor T 
cells. 
Antiserum  Treatment.  Antisera to the CRI of A/J  anti-ABA antibodies were prepared  and 
quantitated as described (15).  1 ×  108 immune lymph node cells were incubated for 45 rain at 
4°C anti-CRI antibodies (25 ~tg idiotype-binding capacity) in a  1-ml vol of HBSS.  The cells 
were then washed twice, pelleted, and resuspended in 1 ml of a  1:10 dilution of Low-Tox rabbit 
complement (Cedarlane Laboratories, London, Ontario, Canada) for 30 min at 37°C. The cells 
were  then washed  twice in chilled HBSS,  recounted, and resuspended for cell transfer. The 
number of cells transferred was determined by the viability counts of treated cells. 
Anti-Thy-1.2 hybridoma antibodies were kindly provided by Dr. P. Lake, University  College, 
London, England. Briefly, 1 ×  108 cells were incubated with 1 ml of 1:20 dilution ofanti-Thy- 
1.2  hybridoma antibodies for 45 min at 0°C, washed  once in chilled HBSS,  and incubated 
again with 1 ml of a  1  : 10 dilution of Low-Tox rabbit complement for 30 rain at 37°C. The cells 
were then washed twice in HBSS then counted and adjusted to the appropriate concentration 
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Results 
Treatment of Immune Lymph Node (LN)  Cells with Anti-CRI Antibodies and Complement 
Rendered them Nonsusceptible to Suppression by Anti-Idiotypic Ts2.  To investigate the target 
of anti-idiotypic Tse, we first determined whether we could transfer immunity into 
BALB/c  mice  that  had  been  previously  injected with  CRI-SC  to  stimulate  anti- 
idiotypic Tsz responses. To transfer immunity, ABA-immune LN cells from BALB/c 
or C.AL-20 mice were used.  In  addition, we  investigated the effect of treating the 
immune LN cells with anti-CRI antibodies and complement just before the passive 
transfer of immunity. 
The results of a representative experiment are depicted in Fig.  1. It was found that 
BALB/c ABA-immune LN cells transferred significant levels of immune reactivity 
into syngeneic BALB/c mice that  had been injected with CRI-SC  7 d  earlier. The 
effectiveness of the transfer was  not  influenced appreciably when  the lymph node 
cells  were  treated  with  anti-CRI  and  complement.  Immune  LN  cells  taken  from 
C.AL-20  mice,  when  treated  with  complement  alone  as  control,  also  transferred 
significant immunity into normal nontreated BALB/c mice. However, such immune 
T  cells failed to transfer immunity into CRI-SC-pretreated BALB/c mice. Of partic- 
ular  interest  was  the observation that  the  failure of C.AL-20-immune LN cells to 
transfer immunity into CRI-SC treated BALB/c mice could be effectively reversed by 
treating the immune LN cell population with anti-CRI antibodies and complement. 
From  this  experiment, we  can  first  conclude that  the  effector TDn  cell  is  itself 
insensitive to treatment with anti-CRI antibodies and complement. Second, as shown 
previously and documented again herein, injection of CRI-SC into BALB/c induced 
efferent suppression  via  the elicitation of anti-idiotypic Ts2 ceils.  Third,  and  most 
important, there are idiotype-bearing cells that reside within the immune LN popu- 
lation that  are apparently required for the expression of Ts2 function. When these 
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FIO.  i.  Treatment of immune LN cells with anti-CRT antibodies and complement rendered them 
nonsusceptible to suppression by anti-idiotypic Ts2. Groups of normal BALB/c mice were injected 
with  5  X  10  7 BALB/c  CRI-SC  to  induce  anti-idiotypic  Ts~.  7  d  later,  these  animals  were  the 
recipients  of immune  LN  ceils.  These  immune  LN  ceils  were  obtained  from  other  groups of 
BALB/e or C.AL-20 mice that had been injected  with 3 ×  107-6  X  107  ABA-SC s.c.  5 d  earlier. 
Before transfer into the appropriate recipients, these immune LN cells were first treated with either 
complement (C') alone as control, or with anti-CRI antibodies and complement. 5 x  107 immune 
LN cells in 0.5 ml were then injected intravenously into the appropriate recipients. Within t h after 
cell transfer, the animals were challenged with 30 #1 of the diazonium salt and increases in footpad 
swelling were measured 24 h after challenge. Each bar represents the mean ±  SEM of measurement 
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idiotype-bearing cells were removed, the remaining cells were able to transfer DTH 
in the presence of Ts~. 
We designed a second experimental protocol to obtain additional evidence for the 
existence of an idiotype-bearing cell serving as target of Ts2. Anti-CRI Ts2 generated 
in BALB/c were mixed with C.AI-20 immune LN cells which had been treated earlier 
with anti-CRI antibodies and complement or complement alone as a control. These 
cells were then cotransferred to naive BALB/c recipients which were then challenged 
within  1 h  after cell transfer. The result of such an experiment is shown in Fig. 2. As 
can be seen, normal BALB/c spleen cells, when cotransferred with immune LN cells 
taken from C.AL-20 mice, did  not  interfere with their ability to transfer immunity 
into  normal  BALB/c  mice.  Immunity was  transferred  irrespective of whether  the 
immune  LN  cells  had  been  treated  with  anti-CRI  antibodies  and  complement  or 
complement  alone.  However, spleen  cells obtained  from BALB/c  mice treated  7 d 
earlier  with  CRI-SC,  when  cotransferred  with  ABA-immune  LN cells  taken  from 
C.AL-20  mice,  inhibited  their  ability  to  transfer  immunity.  This  inhibition  was 
eliminated if the immune LN cells were first treated with anti-CRI and complement. 
Therefore, using two different experimental approaches, we have provided substantial 
evidence that an idiotype-bearing cell is required for the expression of the suppressor 
activity of anti-idiotypic Ts2 suppression. 
Interaction of Anti-Idiotypic  Tsz with Its Appropriate Target Results in an Idiotype-nonspecific 
Suppression.  As  discussed  above,  the  effeetor TDn  cell  in  A/J  and  C.AL-20  mice 
appears not to bear detectable idiotype on its surface. Accordingly, we must conclude 
that the final suppression which limits TDH activity, and which occurs after interac- 
tions between Ts2 and their idiotypic target, is not idiotype specific. 
To determine directly whether idiotype-nonspecific suppression indeed occurs, we 
mixed BALB/c anti-CRI Ts~ with BALB/c immune LN cells in a  cotransfer experi- 
ment. In addition we also added a  defined number of C.AL-20-immune LN cells as 
potential targets of Ts2 or B 10.D2-immune LN cells as a control (C.AL-20 and B 10.D2 
are CRI  + and CRI- strains, respectively. Both strains as well as BALB/c are H-2d). 
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Fie.  2.  Failure of Ts2 to block the passive transfer of immunity if the immune LN cells  had been 
treated with anti-CRI antibodies and complement. Normal BALB/c mice were injected with 5 × 
107 BALB/c CRI-SC i.v.;  7 d later, they were the donors of Ts2. C.AL-20 mice were injected with 
3 ×  107-6 ×  107 C.AL-20 ABA-SC s.c. 4-5 d  later, they were the donors of immune LN cells.  5 × 
107 Ts2 or normal BALB/c spleen cells  were mixed with 5 ×  107 immune LN cells  either treated 
with complement  (C')  alone  as  control  or with anti-CRI  antibodies  and  complement. The cell 
mixture (in 0.5 ml) was then injected i.v. into normal BALB/c mice. Footpad challenges were done 
within one h after cell transfer, and increases in footpad swelling were measured 24 h after challenge. 
Each bar represents the mean -I- SEM of measurement of at least  four mice. 1420  ANTIGEN- AND  RECEPTOR-DRIVEN  REGULATORY  MECHANISMS 
The results of such an experiment are shown in Fig. 3.  BALB/c immune LN cells, 
when cotransferred with normal BALB/c spleen cells and C.AL-20 immune LN cells, 
transferred significant degrees of immunity  into syngeneie BALB/c  mice.  BALB/c- 
immune LN cells, when mixed with BALB/c anti-CRI Ts2 in the presence of B10.D2- 
immune LN cells, likewise still retained their ability to transfer immunity. However, 
BALB/c-immune  LN  cells,  when  mixed  with  BALB/c  anti-idiotypic  Ts  in  the 
presence  of  a  defined  number  of  C.AL-20-immune  LN  cells,  failed  to  transfer 
immunity. Therefore, after anti-idiotypic  Ts2 interacts with its idiotype-bearing target, 
the final suppression appears to be idiotype nonspecific. Furthermore, using a different 
experimental protocol,  in  this case transferring  BALB/c Ts2  and  C.AL-20-immune 
LN  cells into  normal  BALB/c  animals  that  were  then  immunized  subcutaneously 
with ABA-SC (and footpad challenged 5  d  later), similar results have been obtained 
(data not shown). 
The  Targets of Ts~ Are  T  Cells.  In an  attempt  to characterize further  the cellular 
nature  of the  idiotype-bearing cells residing in  the  immune  lymph  node,  we  next 
investigated  whether  treatment  with  anti-Thy-1  and  complement  eliminates  their 
activity. 
The results of such an experiment are shown in Fig. 4. BALB/c immune LN cells, 
when  cotransferred with  BALB/c Ts2  transfer significant degrees of immunity  into 
syngeneic BALB/c mice. BALB/c-immune LN cells, when mixed with BALB/c Ts2, 
in the presence of C.AL-20-immune LN cells that have been treated with complement 
alone  as control,  failed to  transfer  immunity.  However,  BALB/c-immune  LN  cells 
when mixed with BALB/c Ts in the presence of C.AL-20-immune LN cells that had 
been treated with anti-Thy-1 plus complement regain their ability to transfer immu- 
nity. Therefore, we can conclude that  the tragets of Ts2 are Thy-l-bearing, CRI + T 
cells. 
Discussion 
The  experiments  reported  in  this  communication  serve  to  extend  our  previous 
observations on the T  cell-T cell interactions in the ABA-specific suppressor pathway 
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FIG. 3.  By providing the appropriate CRI  ÷ target, the suppression observed in  the cotransfer 
experiment  becomes idiotype nonspecific. BALB/c mice injected 7 d earlier with 5 ×  107 BALB/c 
CRI-SC (i.v.) were the donors of Ts2. Another group of BALB/c, C.AL-20, and B10.D2 animals 
were immunized with 3 ×  107 ABA-SC s.c. and 4-5 d later, they were the donors of immune TDH 
cells. In a cotransfer experiment,  5 X 107 Ts2 were mixed with 5 ×  107 immune TDn and l X 107 
various Ts2 targets (from C.AL-20 or B10.D2 mice) in 0.5 ml. The cell mixtures were then injected 
intravenously into groups of normal BALB/c recipients. Within I h after cell transfer, the animals 
were challenged in the footpad with 30 #l of the diazonium salt and increases in footpad swelling 
measured 24 h later. Each bar represents the mean ± SEM of measurement of at least four mice. SY,  NISONOFF,  GERMAIN,  BENACERRAF,  AND  GREENE  1421 
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FIG.  4.  The CRI + targets of Ts2 are T  cells. BALB/c mice injected with 5 X  107 BALB/c CRI-SC 
7 d  earlier were the donors of suppressor T  cells. BALB/c mice immunized subcutaneously with 3 
x  107 ABA-SC 4-5 d  earlier were the donors of immunme TDH cells. C.AL-20 mice immunized 
subcutaneously with 3 X  107 ABA-SC 7 d earlier were the donors of Ts2 targets. The experimental 
protocol is exactly the same as the one described in Fig.  3, except that C.AL-20-immune LN cells 
were  first  treated  with  complement  (C')  alone as control  or with  anti-Thy-I  (0)  antibodies and 
complement. The cell  mixtures were then injected  intravenously into groups of normal BALB/c 
recipients. Within  1 h  after cell transfer, the animals were challenged in the footpad with 30 p.l of 
the diazonium salt and increases in footpad swelling measured 24 h  later. Each bar represents the 
mean ±  SEM of measurement of at least four mice. 
(1, 2). In this suppressor pathway, idiotype and anti-idiotype interactions have been 
shown to play a decisive role in the propagation of suppressor signals. 
We have herein provided evidence for the existence of an idiotype-bearing T  cell 
subpopulation that resides in the immune LN cell population, and which is required 
for the function of anti-idiotypic suppressor T  cells (Ts2). These idiotype-bearing T 
cells  have  been  termed  the  Ts3  subset.  These results  are  compatible  with  reports 
defining T  cell-T cell interactions in the activation of many different T  cell subsets 
(16-20). 
These studies are consistent with an earlier finding on the suppression of contact 
sensitivity to  DNFB  (12).  It  was  observed that  Ts that  block the efferent limb  of 
sensitivity can inhibit the passive transfer of immunity mediated by DNFB-immune 
TDH cells. However, these Ts failed to inhibit the passive transfer of immunity if the 
TDn cells were  obtained  from  animals  pretreated with  cyclophosphamide, a  drug 
known to eliminate suppressor T  cell precursors (21-23). The latter observations and 
the results described herein provide conclusive evidence that LN cells from sensitized 
mice contain not only TDH cells, but also another T  cell subpopulation which serves 
as  target  of efferent Ts.  Furthermore,  it  was  previously shown  that  the  auxiliary 
suppressor T  cells (Ta~) in the DNFB system are sensitive to adult thymectomy and 
bear I-J determinants. If indeed Ts3, in the ABA system, are similar to, if not identical 
to, the Taux subset, we expect the precursors of Ts~ to be sensitive to cyclophosphamide 
or to adult thymectomy and possibly to bear I-J-subregion-encoded determinants. 
We should also consider our current understanding of the generation of Ts3 cells. 
Ts3  were  activated  by  subcutaneous  immunization  with  ABA-SC  but  were  not 
induced by intravenous injection of the same antigen. This latter route of administra- 
tion  favors  the  activation  of first-order,  idiotype-bearing suppressor  T  cells  (Tsl). 
Furthermore, only ABA-immune LN T  cells--but not normal T  cells--can provide 
the  relevant  idiotypic target  for Ts2  (M.-S.  Sy,  unpublished  results).  It  might  be 
postulated that the activation of Ts3 might require two signals:  one provided by the 1422  ANTIGEN-  AND RECEPTOR-DRIVEN REGULATORY MECHANISMS 
antigen, possibly in the context of H-2 antigen, and the additional signal provided by 
anti-idiotypic Tsz. The postulate that appropriate activation of T  cells, similar to the 
activation of B  cells, might  require two different signals  has  received considerable 
support  (24).  Recently, we  have  obtained  evidence indicating  that  Ts~  activation 
requires two discrete signals (25), and it should also be noted that optimal activation 
of helper T  cells and cytotoxic T  cells also requires two types of signals (17,  26). 
More important, the demonstration of such an idiotype-bearing T3 cell serving as 
target of Ts2 has resolved some of our earlier unexplained data. Specifically, we had 
observed and could not readily explain how Ts2 cells were able to suppress apparently 
idiotype-negative effector TDn cells (6,  11).  It is now apparent that the relationship 
between Ts2 and  Ts3 is  governed by  interactions  that  relate to  anti-idiotypic and 
idiotypic  structures  either  present  on  their  cell  surface  or  their  soluble  products. 
However, the final manifestation  of suppression  may be idiotype nonspecific. This 
latter notion was  supported  by our observation  that  by providing the  appropriate 
idiotype-bearing Ts3  (from C.AL-20  mice)  relevant to  the  anti-diotypic Ts2  (from 
BALB/c mice), suppression can indeed occur across an allotype barrier. This experi- 
ment provides strong evidence that Ts3 are indeed the effector Ts. However, the exact 
mechanism  that  allows  Ts3  to  act  across  an  allotype  barrier  is  not  clear,  and 
experiments are now in progress to determine whether the final suppression mediated 
by Ts3 is antigen specific. 
There are  also  several  questions  regarding Ts3 that  remain  to be answered.  We 
should consider the possibility that Ts3 is a later stage of differentiation of the antigen- 
specific idiotypic Ts~ after it has interacted with antigen and  anti-idiotypic Tsz. In 
this regard, we have recently found that whereas Tsl cells are Lyt-1+2,3  -, Ts3 ceils are 
Lyt-l-2,3  ÷  (M.-S.  Sy,  M.  Takaoki,  A.  Nisonoff, M.  H.  Dietz,  R.  N.  Germain,  B. 
Benacerraf, and M. I. Greene, manuscript in preparation). 
We  have  recently demonstrated  that  anti-idiotypic Tsz produce a  TsF  that  we 
termed TsF2  (8).  Similar to the dichotomy between Tsl and Ts2, TsF2 differs from 
TsF~  with  respect  to  receptor  specificity,  mode  of action,  and  apparent  genetic 
restriction. TsF2 bears anti-idiotypic determinants and  inhibits  the development of 
ABA-specific DTH by suppressing the elicitation phase of the immune response. The 
observation that Ts2 and Ts3 interaction is necessary for the manifestation of suppres- 
sor  function  suggests  that  Ts3  may  also  be  required  for  the  function  of TsF2. 
Experiments are now in progress to determine whether TsF2 function also requires the 
presence of Ts3. 
Because our previous results indicated that Ts2 require both H-2 and Igh-1 identity 
between donors of Ts2 or TsF2 and the recipients for successful transfer of suppression 
(8), we considered that Ts2 were functionally H-2 restricted as well as Igh restricted. 
Our present  results indicate that Ts2 and Ts3 may be functionally related by their 
idiotypic and anti-idiotypic structures. It is possible however that the observed H-2 
restriction may, in fact, occur through events related to Ys3 activity, for example, the 
interaction between Ts3 and TDH cells.  Therefore, the possibility must be entertained 
that two different subsets ofTs (Ts2 and Ts3) may contribute independently to dictate 
H-2 and Igh restrictions, and that this dual restriction may not be the function of a 
single Ts2. 
The observation that the final suppression of ABA reactivity appears to be idiotype SY,  NISONOFF, GERMAIN, BENACERRAF, AND GREENE  1423 
nonspecific (because the TDn and Tsn do not, of necessity, share the same idiotype) 
differs from the earlier reports of Owen et  al.  (9)  in  the regulation  of the humoral 
response to ABA-KLH.  In  the  antibody response,  anti-idiotypic  suppressor T  cells 
only inhibit  that portion of the anti-ABA antibodies that bear the major CRI with 
little effect on the total anti-ABA response. It is possible and indeed likely, based on 
experiments reported earlier  (27),  that  in  the  antibody response,  anti-idiotypic Ts2 
may be able to interact  directly with  the  corresponding CRI-bearing B  cells.  This 
would be consistent with observations that suppression occurs only in the CRI-bearing 
portion  of the  anti-ABA  antibodies.  Ts2 cells  may be decisive in  the  regulation  of 
antibody responses, whereas Tss subsets may play a  lesser or alternate role. Experi- 
ments are now in progress to determine whether by providing ABA-primed Ts3 cells 
we can suppress both the CRI bearing and the non-CRI-bearing anti-ABA antibody 
response in vitro and in vivo. 
In conclusion, it is clear that a  subset of T  cells which may be the last link in the 
suppressor T  cell network appears concurrently with T  effector cells. Analysis of the 
properties of this subset, termed Ts3, may further our understanding  of the genetic 
restriction and of the mechanism of suppression of T  cell reactions. 
Summary 
The suppressor pathway that regulates the T  cell response to p-azobenzenearsonate 
(ABA)-coupled  cells  has  been  studied.  It  has  been  found  that  the  ability  of anti- 
idiotypic second-order T  suppressor cells  (Ts2)  to inhibit T  cell-dependent  delayed- 
type hypersensitivity (DTH) responses depended upon the presence of cross-reactive- 
idiotype  (CRI)-bearing T  cells present in ABA-primed mice. This suppressor T  cell 
subset, termed Ts~, coexists with CRI-negative T  cells that mediate DTH in vivo. It 
appears that antigen-activated CRI  + Ts~ require signals from the anti-CRI Ws2 subset 
to suppress DTH reactions in an idiotype-nonspecific manner. The relevance of these 
observations to a comprehensive scheme of T  and B cell regulation is discussed. 
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